WFDC11 rs6065855: What Your Genotype Means
The genetic variant rs6065855 is a single nucleotide polymorphism located within the WFDC11 gene. It has been identified in scientific research as being associated with measurements of 3-hydroxy-1-methylpropylmercapturic acid in the human body.
What each genotype means
Typical metabolite levels
This genotype represents the most common genetic configuration at this location. Research indicates this variant is associated with levels of 3-hydroxy-1-methylpropylmercapturic acid, a metabolite often studied in the context of environmental exposure monitoring. This finding is based on statistical associations in population studies and does not indicate a health condition.
This genotype is the most frequently observed configuration across most global populations.
Varied metabolite levels
Carrying one copy of the variant allele may be associated with slight differences in the processing or measurement of 3-hydroxy-1-methylpropylmercapturic acid compared to the common genotype. These associations are based on broad population-level data and do not provide specific medical or diagnostic information about your personal health.
This heterozygous genotype is found at varying frequencies depending on ancestral background, appearing in a significant minority of individuals.
Distinct metabolite levels
Individuals with this genotype may show different statistical trends regarding 3-hydroxy-1-methylpropylmercapturic acid levels compared to those with the A allele. Current evidence links this variant to these specific metabolite measurements, but the clinical significance of these variations remains limited and is not considered a marker for disease.
This genotype is less common than the AA configuration and its prevalence varies significantly across different global populations.
Understanding the rs6065855 Variant
The variant rs6065855 is a specific change in the DNA sequence of the WFDC11 gene. In genetics, a single nucleotide polymorphism, or SNP, represents a variation at a single position in the DNA sequence among individuals. Researchers track these variations to understand how they might influence biological traits or susceptibility to certain conditions. The rs6065855 variant is cataloged in public databases that aggregate findings from genome-wide association studies (GWAS). These studies look across the entire genome to find statistical links between specific genetic markers and measurable traits. It is important to note that a statistical association does not necessarily imply a direct cause-and-effect relationship between the variant and a specific health outcome, but rather highlights a correlation that warrants further scientific investigation.
The Role of the WFDC11 Gene
The WFDC11 gene encodes a protein belonging to the WAP-type four-disulfide core (WFDC) domain family. Proteins in this family are characterized by a specific structural motif containing eight cysteine residues that form four disulfide bonds. This structural arrangement is critical for the protein's function as a protease inhibitor. Protease inhibitors are molecules that regulate the activity of enzymes known as proteases, which break down proteins. By inhibiting these enzymes, WFDC11 plays a role in various biological processes, including the regulation of proteolytic activity and potentially the innate immune response. Because it is a secreted protein, it may function in extracellular environments to maintain balance in biochemical pathways. Understanding the normal function of this gene provides context for why variations within its sequence might be studied in relation to metabolic or physiological markers.
Research Associations and Evidence Strength
The primary association for rs6065855 documented in the GWAS Catalog is with the measurement of 3-hydroxy-1-methylpropylmercapturic acid. This compound is a metabolite, often studied in the context of environmental exposure or metabolic processing. The evidence strength for this association is currently categorized as moderate. In the context of genetic research, moderate evidence suggests that while a statistical signal has been observed in large-scale studies, the biological mechanism linking the specific SNP to the metabolite level is not yet fully elucidated. Scientific literature often identifies these signals as starting points for deeper functional studies. Because the evidence is based on population-level associations, it is not currently used for clinical diagnostics or individual health predictions. Further research is required to determine the precise impact of this variant on human physiology.
Population Frequency and Interpretation
Information regarding the specific frequency of the rs6065855 variant across different global populations is currently limited in public genetic catalogs. Genetic variants can vary significantly in frequency depending on ancestral background, with some being common in certain groups and rare in others. Without comprehensive data from large-scale population sequencing projects, it is difficult to provide a precise estimate of how often this variant appears in the general population. When interpreting genetic information, it is essential to recognize that most traits are polygenic, meaning they are influenced by many different genes and environmental factors working in concert. A single SNP like rs6065855 typically has a very small effect size on its own. Therefore, this information should be viewed as a small piece of a much larger, complex biological puzzle rather than a definitive indicator of a specific trait or health status.
What You Can Do With This Information
Genetic information regarding variants like rs6065855 is primarily intended for educational and research purposes. Because the association with 3-hydroxy-1-methylpropylmercapturic acid is based on population-level statistical data, it does not provide actionable medical advice for an individual. You cannot use this information to diagnose a condition or predict a specific health outcome. If you have questions about your genetic data or how it relates to your health, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can help you interpret your results within the context of your overall health history and lifestyle. Avoid making any changes to your health regimen or diet based solely on findings from genetic databases, as these tools are designed to advance scientific knowledge rather than provide personalized medical guidance.
How common is this variant?
There is no specific population frequency data recorded for this variant in major public catalogs at this time.
Frequently asked questions
What is the WFDC11 gene?
The WFDC11 gene provides instructions for making a protein that acts as a protease inhibitor. It is involved in regulating enzyme activity and may play a role in the body's immune response.
Is rs6065855 associated with a disease?
Currently, rs6065855 is associated with measurements of a specific metabolite in the body. It is not classified as a diagnostic marker for any specific disease.
Can I use this information to change my diet?
No, this genetic information is for educational purposes and does not provide a basis for dietary changes. Always consult with a healthcare provider before making significant changes to your nutrition or health habits.
Where can I find more information about my own genetics?
You can discuss your genetic data with a doctor or a certified genetic counselor. They are trained to help you understand what your results mean in the context of your personal health.
Sources & further reading
Educational information only, last refreshed 10/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6065855?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in WFDC11
Rare missense coding variant within the whey acidic protein (WAP) domain gene WFDC11 evaluated for protein alteration and clinical classification.
This variant is associated with susceptibility to Parkinson disease.
This variant has been identified in studies regarding depressive symptom measurements.
This variant is associated with high-density lipoprotein cholesterol measurements.
This variant is linked to levels of phospholipid transfer protein in the blood.
This variant is associated with variations in elafin measurement in blood.
